Post-Doctoral Position in Cancer Immunotherapy
We are recruiting a post-doctoral fellow to develop in vivo reprogramming as a novel approach to cancer immunotherapy.
This position is part of a collaborative project between Pereira Lab and Asgard Therapeutics, supported by the CanFaster program.
Key requirements are a PhD in immunology, immune-oncology, tumor immunology, or similar; documented knowledge in tumor immunology, with practical experience in in-vivo; strong publication record and oral and written proficiency in English.
Deadline for applications is December 19th 2022.
More information about the position here.